Anti-HIV passive immunization with human neutralizing monoclonal antibodies (nmAbs) has made exciting gains: (i) identification of the HIV envelope V2 apex as a new in vivo protective epitope, (ii) a novel clade C SHIV for challenge studies, and (iii) a highly protective, trispecific nmAb. Potent, broad-spectrum protection by nmAbs holds promise.

中文翻译：

---

抗艾滋病毒被动免疫：武器库中的新武器

人类中和性单克隆抗体（nmAbs）的抗HIV被动免疫取得了令人兴奋的进展：（i）将HIV包膜V2顶点鉴定为一种新的体内保护性表位，（ii）用于攻击研究的新型C SHIV进化枝，和（ iii）具有高度保护性的三特异性nmAb。nmAbs的强效，广谱保护前景广阔。